Stay updated on Efruxifermin in NASH Subjects Clinical Trial

Sign up to get notified when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efruxifermin in NASH Subjects Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Access to the study record is blocked by a 403 Forbidden error page, replacing the usual study details. The page now displays a 403 message and a generic site footer instead of the study content.
    Difference
    18%
    Check dated 2026-09-23T00:58:26.000Z thumbnail image
  2. Check
    13 days ago
    Change Detected
    Summary
    The page’s revision label was updated from v3.6.6 to v3.7.0, indicating a newer software build of the page.
    Difference
    0.0%
    Check dated 2026-09-16T00:12:34.000Z thumbnail image
  3. Check
    20 days ago
    No Change Detected
  4. Check
    27 days ago
    Change Detected
    Summary
    Revision updated from v3.6.5 to v3.6.6. This indicates a small platform update rather than changes to the study details or the information shown on the page.
    Difference
    0.0%
    Check dated 2026-09-01T19:12:51.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.4 to v3.6.5, signaling a small backend/content update to the page template.
    Difference
    0.0%
    Check dated 2026-08-11T22:19:03.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4. This appears to be a minor version update that does not alter the study content or user-facing features.
    Difference
    0.0%
    Check dated 2026-07-21T23:12:46.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Steatotic Liver Disease was added to the page's disease terms and Fatty Liver Disease was removed. This update updates the page’s terminology to reflect current naming conventions for liver disease and may affect how readers locate information related to these conditions.
    Difference
    0.0%
    Check dated 2026-07-14T18:46:36.000Z thumbnail image

Stay in the know with updates to Efruxifermin in NASH Subjects Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efruxifermin in NASH Subjects Clinical Trial page.